» Articles » PMID: 25933125

Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2015 May 2
PMID 25933125
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

A versatile method for orchestrating the formation of side chain-to-tail cyclic peptides from ribosomally derived polypeptide precursors is reported. Upon ribosomal incorporation into intein-containing precursor proteins, designer unnatural amino acids bearing side chain 1,3- or 1,2-aminothiol functionalities are able to promote the cyclization of a downstream target peptide sequence via a C-terminal ligation/ring contraction mechanism. Using this approach, peptide macrocycles of variable size and composition could be generated in a pH-triggered manner in vitro or directly in living bacterial cells. This methodology furnishes a new platform for the creation and screening of genetically encoded libraries of conformationally constrained peptides. This strategy was applied to identify and isolate a low-micromolar streptavidin binder (KD = 1.1 μM) from a library of cyclic peptides produced in Escherichia coli, thereby illustrating its potential toward aiding the discovery of functional peptide macrocycles.

Citing Articles

Genetic Code Expansion: Recent Developments and Emerging Applications.

Huang Y, Zhang P, Wang H, Chen Y, Liu T, Luo X Chem Rev. 2024; 125(2):523-598.

PMID: 39737807 PMC: 11758808. DOI: 10.1021/acs.chemrev.4c00216.


p-Chloropropynyl Phenylalanine, a Versatile Non-Canonical Amino Acid for Co-Translational Peptide Macrocyclization and Side Chain Diversification.

Osorio Franco H, Le A, Chang N, Hartman M Chembiochem. 2023; 24(11):e202300020.

PMID: 37156744 PMC: 11165969. DOI: 10.1002/cbic.202300020.


Incorporation of Non-Canonical Amino Acids into Antimicrobial Peptides: Advances, Challenges, and Perspectives.

Du Y, Li L, Zheng Y, Liu J, Gong J, Qiu Z Appl Environ Microbiol. 2022; 88(23):e0161722.

PMID: 36416555 PMC: 9746297. DOI: 10.1128/aem.01617-22.


MOrPH-PhD: A Phage Display System for the Functional Selection of Genetically Encoded Macrocyclic Peptides.

Gu Y, Iannuzzelli J, Fasan R Methods Mol Biol. 2021; 2371:261-286.

PMID: 34596853 PMC: 8493807. DOI: 10.1007/978-1-0716-1689-5_14.


Genetic Code Expansion in the Engineered Organism Vmax X2: High Yield and Exceptional Fidelity.

Gonzalez S, Ad O, Shah B, Zhang Z, Zhang X, Chatterjee A ACS Cent Sci. 2021; 7(9):1500-1507.

PMID: 34584951 PMC: 8461772. DOI: 10.1021/acscentsci.1c00499.


References
1.
Guillen Schlippe Y, Hartman M, Josephson K, Szostak J . In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors. J Am Chem Soc. 2012; 134(25):10469-77. PMC: 3384292. DOI: 10.1021/ja301017y. View

2.
Aboye T, Camarero J . Biological synthesis of circular polypeptides. J Biol Chem. 2012; 287(32):27026-32. PMC: 3411040. DOI: 10.1074/jbc.R111.305508. View

3.
Morimoto J, Hayashi Y, Suga H . Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2. Angew Chem Int Ed Engl. 2012; 51(14):3423-7. DOI: 10.1002/anie.201108118. View

4.
Arnison P, Bibb M, Bierbaum G, Bowers A, Bugni T, Bulaj G . Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 2012; 30(1):108-60. PMC: 3954855. DOI: 10.1039/c2np20085f. View

5.
Frost J, Vitali F, Jacob N, Brown M, Fasan R . Macrocyclization of organo-peptide hybrids through a dual bio-orthogonal ligation: insights from structure-reactivity studies. Chembiochem. 2012; 14(1):147-60. DOI: 10.1002/cbic.201200579. View